Berger, Juliette
Vigan, Marie
Pereira, Bruno
Nguyen, Thu Thuy
Froissart, Roseline
Belmatoug, Nadia
Dalbiès, Florence
Masseau, Agathe
Rose, Christian
Serratrice, Christine
Pers, Yves-Marie
Bertchansky, Ivan
Camou, Fabrice
Bengherbia, Monia
Bourgne, Céline
Caillaud, Catherine
Pettazzoni, Magali
Berrahal, Amina
Stirnemann, Jérôme
Mentré, France
Berger, Marc G. http://orcid.org/0000-0003-1858-0587
Funding for this research was provided by:
SANOFI-GENZYME (GZ-2010-10458)
Association Vaincre les Maladies Lysosomales (VML S9MBerger)
CHU Clermont-Ferrand (PHRC2010-AOI MBerger)
Article History
First Online: 21 August 2018
Compliance with ethical standards
:
: This study was supported by grants from Genzyme SA then Sanofi-Genzyme (Grant no. GZ-2010-10458) and from Vaincre les Maladies Lysosomales (patient association, Paris, France) (Grant no. VML S9MBerger) and research funding from CHU de Clermont-Ferrand as the promotor establishment, Marc G. Berger being an investigator coordinator (Grant no. PHRC2010-AOI MBerger).
: Nadia Belmatoug, Christian Rose, Marc G. Berger, and Christine Serratrice received honoraria from Sanofi-Genzyme and Shire Corporation for travel and speaking or expert missions; Yves-Marie Pers and Jérôme Stirnemann received travel fees from Sanofi-Genzyme. Nadia Belmatoug, Christian Rose, and Marc G. Berger are scientific leaders of research projects receiving research grants from Sanofi-Genzyme and Shire Corporation. Christian Rose is a scientific leader of a research project receiving research grants from Sanofi-Genzyme. Nadia Belmatoug, Christine Serratrice, Fabrice Camou, and Marc G. Berger are members of the scientific board organized by Sanofi-Genzyme, Shire; Juliette Berger, Marie Vigan, Bruno Pereira, Thu Thuy Nguyen, Roseline Froissart, Florence Dalbiès, Agathe Masseau, Yves-Marie Pers, Ivan Bertchansky, Monia Bengherbia, Céline Bourgne, Catherine Caillaud, Magali Pettazzoni, Amina Berrahal, and France Mentré have no conflicts of interest directly relevant to the contents of this article.